Apellis Pharmaceuticals is a global biopharmaceutical company based in San Francisco, specializing in the development of innovative therapies that have the potential to transform lives.
Their focus on targeted C3 therapies aims to address diseases driven by overactivation of the complement cascade, with a particular emphasis on hematology, ophthalmology, and nephrology.
Generated from their website's infomation